Market Expansion Recent acquisitions of ZyMōt Fertility and obp Surgical demonstrate Cooper Surgical’s active growth strategy in reproductive and surgical technologies, indicating opportunities to offer complementary products or services in fertility treatments and surgical solutions.

Innovation Initiatives The launch of a new single-hand inserter for the Paragard IUD highlights the company’s focus on innovative, user-friendly reproductive health devices, presenting potential sales prospects for advanced delivery systems and contraceptive solutions.

Quality Concerns Ongoing lawsuits related to defective embryo culture media and quality assurance issues suggest a demand for enhanced quality control solutions, testing services, and regulatory compliance support for companies in the fertility device sector.

Industry Presence Participation in prominent events such as ASRM 2025 indicates active engagement in the reproductive and fertility community, creating opportunities for networking, partnerships, and sales of cutting-edge fertility technologies.

Growth Potential With revenue between one and ten million dollars and a specialized focus in medical device manufacturing, Cooper Surgical offers a promising target market for innovative medical technologies and complementary service solutions tailored to mid-sized health tech companies.